New Molecular Biomarkers for the Prognosis and Management of ...

New molecular biomarkers for the prognosis and ... - PubMed

New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era. Anticancer Res. 2009 Aug;29(8):3289-98. Authors. Bridget ...

A promising biomarker is α-methylacyl-CoA racemase (AMACR). This enzyme is involved in oxidative metabolism and synthesis of branched chain fatty acids (56).

The promising role of new molecular biomarkers in prostate cancer

The aim of this systematic review is to provide an overview about recent advances in the discovery of new molecular biomarkers through transcriptomics, ...

Potential molecular biomarkers for the diagnosis and prognosis of ...

Treatment strategies are totally different for different stage diseases. Therefore, it is of great practical significance to study new biomarkers for diagnosis ...

Biomarkers for diagnosis and therapeutic options in hepatocellular ...

These studies have led to identifying several molecular subclasses of HCC that exhibit distinct prognostic and therapeutic implications. This ...

Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline

Numerous tissue-based molecular biomarkers were evaluated for their prognostic capabilities and potential for improving management decisions.

Tumor biomarkers for diagnosis, prognosis and targeted therapy

In recent years, extensive molecular and genetic characterization of disseminated tumor cells and blood-based biomarkers have contributed ...

Biomarker Testing for Cancer Treatment - NCI

tumor testing; tumor genetic testing; genomic testing or genomic profiling; molecular testing or molecular profiling; somatic testing; tumor ...

Current and emerging tissue‐based molecular biomarkers for ...

To improve diagnostic accuracy and to better inform clinical decision making, the development of molecular biomarkers has undergone considerable ...

Biomarkers in Cancer Detection, Diagnosis, and Prognosis - MDPI

Significant molecular and tissue alterations are required for cancer growth. Invaluable clinical data in the form of biomarkers can be generated by analyzing ...

Editorial: New progress in cancer biomarkers and therapy - Frontiers

Of notable importance are cancer biomarkers, which carry substantial clinical implications, aiding in early detection, monitoring treatment progress, and ...

Prognostic and predictive molecular biomarkers in advanced ...

The treatment of the remaining vast majority mCRC patients is still based upon only two molecular determinants: the RAS and BRAF mutational status. New ...

Review Prognostic and Predictive Molecular Biomarkers in Chronic ...

Prognostic markers refer to biomarkers that can provide information regarding the patient's outcome regardless of treatment. These markers are normally ...

Molecular Biomarkers for Melanoma Screening, Diagnosis and ...

Prognostic biomarkers compose the broadest category of biomarkers. In terms of clinical decision impact, they can range from nebulous indicators of survival ...

The ProBio trial: molecular biomarkers for advancing personalized ...

Outcome-adaptive randomization is implemented to early identify promising treatments for a biomarker signature. Biomarker signature-treatment ...

Molecular biomarkers in early stage lung cancer - Rodríguez

Biomarkers may also be useful to better characterize the risk of indeterminate nodules found in the course of screening or to refine prognosis and help in the ...

Molecular Biomarkers in Cancer - MDPI

They can be used as tools for cancer risk assessment, screening and early detection of cancer, accurate diagnosis, patient prognosis, prediction of response to ...

Molecular Biomarkers for the Evaluation of Colorectal Cancer

To develop evidence-based guideline recommendations through a systematic review of the literature to establish standard molecular biomarker ...

Current and Future Trends of Molecular Biomarkers in Prognosis ...

Technological advances have greatly increased our understanding of the molecular basis of systemic diseases, tumor progression and treatment response.

Molecular Biomarkers in the Personalized Treatment of Colorectal ...

Certain biomarkers have been identified that can predict clinical outcome beyond tumor staging, and inform treatment selection. Molecular testing is routinely ...